- Previous close
0.1200 - Open
0.1120 - Bid 0.1070 x --
- Ask 0.1200 x --
- Day's range
0.1060 - 0.1120 - 52-week range
0.1060 - 0.2000 - Volume
61,300 - Avg. Volume
10,156 - Market cap (intra-day)
18.127M - Beta (5Y monthly) 0.33
- PE ratio (TTM)
10.60 - EPS (TTM)
0.0100 - Earnings date 14 Aug 2024
- Forward dividend & yield 0.00 (2.92%)
- Ex-dividend date 7 Nov 2023
- 1y target est
--
Singapore Paincare Holdings Limited, an investment holding company, operates medical clinics in Singapore. It offers pain care services for the treatment of patients suffering from acute and chronic pain, including minimally invasive procedures, cancer pain therapy, pharmacotherapy, and cognitive behavioural therapy, as well as neck pain, lower, spinal stenosis, osteoarthritis, fibromyalgia, frozen shoulder, plantar fasciitis, and tennis elbow pain conditions; and primary care and other services comprising general medical consultations, management of chronic and acute conditions, and dermatology services. The company also offers myofascial pain injections, platelet rich plasma, neuroplasty, necleoplasty, radio frequency ablation, intrathecal pump implants, pulsed radio frequency, spinal cord stimulator, ketamine therapy, and endoscopic laser decompression services. It operates two specialist clinics and five medical clinics, and a physiotherapy centre. The company was founded in 2007 and based in Singapore.
www.sgpaincareholdings.com104
Full-time employees
30 June
Fiscal year ends
Healthcare
Sector
Medical Care Facilities
Industry
Related news
View more
Performance overview: FRQ.SI
Trailing total returns as of 08/11/2024, which may include dividends or other distributions. Benchmark is
.YTD return
1-year return
3-year return
5-year return
Compare to: FRQ.SI
Select to analyse similar companies using key performance metrics; select up to four stocks.
Statistics: FRQ.SI
View moreValuation measures
Market cap
20.52M
Enterprise value
25.12M
Trailing P/E
10.43
Forward P/E
--
PEG ratio (5-yr expected)
--
Price/sales (ttm)
0.76
Price/book (mrq)
0.91
Enterprise value/revenue
0.93
Enterprise value/EBITDA
4.23
Financial highlights
Profitability and income statement
Profit margin
7.15%
Return on assets (ttm)
4.37%
Return on equity (ttm)
10.71%
Revenue (ttm)
27.48M
Net income avi to common (ttm)
1.97M
Diluted EPS (ttm)
0.0100
Balance sheet and cash flow
Total cash (mrq)
7.22M
Total debt/equity (mrq)
49.75%
Levered free cash flow (ttm)
945.5k